Geriatrics - Global Neurology Academy

1-16 of 55

Parkinson’s Research in Focus: Translating Science Into Clinical Progress
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
NeuroFrontiers
Parkinson’s Research in Focus: Translating Science Into Clinical Progress
- Jerome Lisk, MD, MBA, M.S., FAAN
- Michael Salvatore, PhD
- Vicki Nejtek-Salvatore, PhD
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
NeuroFrontiers
Bridging the Diagnostic Gap: Blood Biomarkers in Alzheimer’s Care
- Ashvini Keshavan, MRCP, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiers
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
- Le Hua, MD
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiers
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
- Marc Haut, PhD
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
NeuroFrontiers
Transforming Alzheimer’s Care: Anti-Amyloid Therapies and Emerging Genetic Approaches
- Marc Haut, PhD
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
NeuroFrontiers
Epigenetic Immune Signatures in Alzheimer’s: Implications for Diagnosis and Therapy
- David Gate, PhD
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
NeuroFrontiers
Restoring Immune Balance: Low-Dose IL-2 Shows Promise in Alzheimer’s Research
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
NeuroFrontiers
Early Evidence Supports Videoconference ACT for Dementia Caregivers with Depression
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
NeuroFrontiers
Metabolic Modulation in Alzheimer’s Disease: Early Clinical Signals from a Dapagliflozin Pilot Trial
Managing MS in Older Adults: Top 5 Clinical Considerations
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiers
Managing MS in Older Adults: Top 5 Clinical Considerations
- Yinan Zhang, MD
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiers
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
- Jerome Lisk, MD, MBA, M.S., FAAN
- Emile Maamary
- Mark Elias
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple Sclerosis
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
- Yinan Zhang, MD
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
On the Frontlines of Multiple Sclerosis
Managing MS in Older Adults: Key Considerations for DMTs and Lifestyle Interventions
- Charles Turck, PharmD, BCPS, BCCCP
- Kimberly DiMauro, DO
- Carol Swetlik, MD
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD

Prev
1
2
3
4
Next

1/4